Heart attack drug study halted: personalized blood thinner plan tested
NCT ID NCT03729401
First seen May 21, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study looked at whether giving heart attack patients a personalized blood thinner plan based on their age, health, and genetics could reduce bleeding risks while still preventing future clots. It involved 39 patients who had already been on two blood thinners for a year. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y4W7, Canada
Conditions
Explore the condition pages connected to this study.